Parallel Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.12K | Buy |
45
+12
| +36% | +$1.36K | ﹤0.01% | 2712 |
|
|
2025
Q1 | $3.47K | Hold |
33
| – | – | ﹤0.01% | 2792 |
|
|
2024
Q4 | $3.54K | Buy |
33
+31
| +1,550% | +$3.32K | ﹤0.01% | 2741 |
|
|
2024
Q3 | $200 | Hold |
2
| – | – | ﹤0.01% | 3286 |
|
|
2024
Q2 | $169 | Hold |
2
| – | – | ﹤0.01% | 3200 |
|
|
2024
Q1 | $146 | Hold |
2
| – | – | ﹤0.01% | 3183 |
|
|
2023
Q4 | $143 | Buy |
2
+1
| +100% | +$72 | ﹤0.01% | 3201 |
|
|
2023
Q3 | $60 | Hold |
1
| – | – | ﹤0.01% | 3294 |
|
|
2023
Q2 | $72 | Hold |
1
| – | – | ﹤0.01% | 3296 |
|
|
2023
Q1 | $74 | Hold |
1
| – | – | ﹤0.01% | 3349 |
|
|
2022
Q4 | $67 | Sell |
1
-4
| -80% | -$268 | ﹤0.01% | 3283 |
|
|
2022
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 3335 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | – | – | 3132 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 3198 |
|
|
2021
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 3148 |
|
|
2020
Q1 | – | Sell |
-10
| Closed | -$1K | – | 2528 |
|
|
2019
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 2317 |
|
|
2019
Q3 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 2278 |
|
|
2017
Q3 | – | Sell |
-3
| Closed | – | – | 2168 |
|
|
2017
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2161 |
|